Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.2848
-0.0012 (-0.42%)
Jun 24, 2026, 2:11 PM EDT - Market open
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $1.13 million as of June 24, 2026. Its market cap has decreased by -51.30% in one year.
Market Cap
1.13M
Enterprise Value
1.67M
1-Year Change
-51.30%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $5.42M to $1.13M, a decrease of -79.18%. That is a compound annual growth rate of -13.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 1.13M | -54.34% |
| Dec 31, 2025 | 2.47M | -13.44% |
| Dec 31, 2024 | 2.85M | 10.12% |
| Dec 29, 2023 | 2.59M | -74.89% |
| Dec 30, 2022 | 10.32M | -76.24% |
| Dec 31, 2021 | 43.42M | 34.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.33M |
| Onconetix | 3.33M |
| Virax Biolabs Group | 3.27M |
| Calidi Biotherapeutics | 3.11M |
| Oragenics | 2.68M |
| Bone Biologics | 2.50M |
| Biodexa Pharmaceuticals | 2.29M |
| Valion Bio | 1.60M |